Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gardasil-9 booster after single dose Gardasil
NCT03431246Phase 3Completed
- Sponsor
- Université Laval
- Start
- Oct 2016
- Primary completion
- Nov 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human papillomavirus 9-valent vaccine in human papillomavirus infection, sponsored by Université Laval. Started Oct 2016; status: completed.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT03431246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03431246.